# APREMILAST
> **ANDA211859** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-02-03
## Drug
- **FDA Application Number:** ANDA211859
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APREMILAST
- **Generic name:** Apremilast
- **Active ingredients:** APREMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ZYDUS PHARMS
- **First approval:** 2022-02-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211859)
---
*AI Analytics · CC0 1.0*